מדינה: אירלנד
שפה: אנגלית
מקור: HPRA (Health Products Regulatory Authority)
EPROSARTAN MESYLATE
B & S Healthcare
C09CA02
EPROSARTAN MESYLATE
600 Milligram
Film Coated Tablet
Product subject to prescription which may be renewed (B)
Angiotensin II antagonists, plain
Authorised
2012-11-05
PACKAGE LEAFLET: INFORMATION FOR THE USER TEVETEN 600MG FILM-COATED TABLETS (eprosartan) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. The name of your medicine is Teveten 600mg film-coated Tablets but it will be referred to as Teveten throughout this leaflet. IN THIS LEAFLET: 1. What Teveten is and what it is used for 2. Before you take Teveten 3. How to take Teveten 4. Possible side effects 5. How to store Teveten 6. Further information 1. WHAT TEVETEN IS AND WHAT IT IS USED FOR Teveten is used: to treat high blood pressure. Teveten contains the active ingredient eprosartan. EPROSARTAN belongs to a group of medicines called „angiotensin II receptor antagonists‟. It blocks the action of a substance in your body called „angiotensin II‟. This substance causes your blood vessels to narrow. This makes it more difficult for the blood to flow through the vessels and so your blood pressure increases. By blocking this substance, the vessels relax and your blood pressure decreases. 2. BEFORE YOU TAKE TEVETEN WARNINGS AND PRECAUTIONS DO NOT TAKE TEVETEN IF: you are allergic (hypersensitive) to eprosartan or any of the other ingredien קרא את המסמך השלם
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Teveten 600 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 600mg eprosartan (as eprosartan mesilate). Excipent with known effect; lactose monohydrate. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film coated tablet. _Product imported from Italy:_ White capsule shaped, film-coated tablets with “5046” engraved on one side and plain on the other. 4 CLINICAL PARTICULARS As per PA2007/014/002 5 PHARMACOLOGICAL PROPERTIES As per PA2007/014/002 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Lactose monohydrate Microcrystalline cellulose Pregelatinised maize starch Crospovidone Magnesium stearate _Film-coating:_ Hypromellose Titanium dioxide (E171) Macrogol 400 Polysorbate 80 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf-life expiry date of this product is the date shown on the blister foil and outer package of the product on the market in the country of origin. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 27/11/2015_ _CRN 2169740_ _page number: 1_ 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25°C. 6.5 NATURE AND CONTENTS OF CONTAINER White PVC/aluminium blister packs of 28 tablets. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER B & S Healthcare Unit 4, Bradfield Road Ruislip Middlesex HA4 0NU United Kingdom 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA1328/174/001 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 5 th November 2012 קרא את המסמך השלם